Impact of pulmonary infection on thoracoscopic surgery outcomes in children with CPAM: a retrospective study

Cui-Xia Yuan1, Chun Wu1, Zheng-Xia Pan1

  • 1Department of Cardiothoracic Surgery, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Diorders, Chongqing Key Laboratory of Structural Birth Defect and Reconstruction, Chongqing, China.

BMC Surgery
|March 11, 2025
PubMed

Insights

Pulmonary infection complicates surgical outcomes in children with congenital pulmonary airway malformation (CPAM). Early intervention before infection improves results and reduces risks associated with thoracoscopic surgery for CPAM.

Area of Science:

  • Pediatric Surgery
  • Thoracic Surgery
  • Pulmonology

Background:

  • Pulmonary infection is a frequent complication in pediatric congenital pulmonary airway malformation (CPAM).
  • Surgical intervention is a primary treatment for CPAM.
  • The impact of pulmonary infection on thoracoscopic surgery outcomes in CPAM requires further evaluation.

Purpose of the Study:

  • To assess how pulmonary infection affects outcomes of total thoracoscopic procedures in children with CPAM.
  • To compare surgical outcomes among children with CPAM based on infection status.

Main Methods:

  • A retrospective, single-center study of 154 children with CPAM undergoing thoracoscopic surgery (January 2013-December 2023).
  • Patients were classified into non-infection (NI), hidden infection (HI), and pulmonary infection (PI) groups.
  • Clinical characteristics and operative outcomes were compared across the three groups.

Main Results:

  • The conversion to thoracotomy rate was higher in the PI (29.2%) and HI (23.2%) groups compared to the NI group (14.8%).
  • Operative time and blood loss differed significantly across groups (p<0.05).
  • Pneumothorax incidence varied significantly among groups (p<0.05), unlike atelectasis or pneumonia.

Conclusions:

  • Pulmonary infection, including hidden infections, is common in CPAM and complicates thoracoscopic surgery.
  • Early thoracoscopic intervention before infection onset can optimize surgical outcomes and minimize complications in pediatric CPAM patients.
Abstract

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
138
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
283
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
112